Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-acetylcysteine for clozapine-induced sialorrhea
IRCT20260629069997N1Phase 2Recruiting
- Sponsor
- Kurdistan University of Medical Sciences
- Start
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, triple-blind trial in hypersalivation comparing N-acetylcysteine with Placebo (2 arms). Primary endpoints: Sialorrhea severity, Drooling rate and 2 more. Started Aug 2026; status: recruiting.
02
Drugs
acetylcysteine
03
Conditions
hypersalivation
Beyond the preview
Go deeper on IRCT20260629069997N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20260629069997N1.